Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics

High-quality, 25 nm octahedral-shaped Fe O magnetite nanocrystals are epitaxially grown on 9 nm Au seed nanoparticles using a modified wet-chemical synthesis. These Fe O -Au Janus nanoparticles exhibit bulk-like magnetic properties. Due to their high magnetization and octahedral shape, the hybrids s...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 8; no. 1; pp. 11295 - 19
Main Authors Efremova, Maria V, Naumenko, Victor A, Spasova, Marina, Garanina, Anastasiia S, Abakumov, Maxim A, Blokhina, Anastasia D, Melnikov, Pavel A, Prelovskaya, Alexandra O, Heidelmann, Markus, Li, Zi-An, Ma, Zheng, Shchetinin, Igor V, Golovin, Yuri I, Kireev, Igor I, Savchenko, Alexander G, Chekhonin, Vladimir P, Klyachko, Natalia L, Farle, Michael, Majouga, Alexander G, Wiedwald, Ulf
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 26.07.2018
Nature Publishing Group UK
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:High-quality, 25 nm octahedral-shaped Fe O magnetite nanocrystals are epitaxially grown on 9 nm Au seed nanoparticles using a modified wet-chemical synthesis. These Fe O -Au Janus nanoparticles exhibit bulk-like magnetic properties. Due to their high magnetization and octahedral shape, the hybrids show superior in vitro and in vivo T relaxivity for magnetic resonance imaging as compared to other types of Fe O -Au hybrids and commercial contrast agents. The nanoparticles provide two functional surfaces for theranostic applications. For the first time, Fe O -Au hybrids are conjugated with two fluorescent dyes or the combination of drug and dye allowing the simultaneous tracking of the nanoparticle vehicle and the drug cargo in vitro and in vivo. The delivery to tumors and payload release are demonstrated in real time by intravital microscopy. Replacing the dyes by cell-specific molecules and drugs makes the Fe O -Au hybrids a unique all-in-one platform for theranostics.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-018-29618-w